Table S1 - Early Potent Protection against Heterologous SIVsmE660 Challenge Following Live Attenuated SIV Vaccination in Mauritian Cynomolgus Macaques

Concordant outcome in productive infection by vRNA and virus isolation in MCM challenged with serial dilutions of the SIVsmE660 challenge stock. Nt  =  not tested. The number of infected macaques is shown for each pair of macaques challenged. vRNA  =  viral RNA; VI  =  virus isolation.
(PDF)